Moderna plans to test booster doses of variant-specific vaccine for NIH study

CNBC's Meg Tirrell reports that Modena has shipped doses of its variant-specific vaccine to the National Institutes of Health for a clinical study, and the company has also boosted its manufacturing targets for the vaccine.
Wed, Feb 24 20214:35 PM EST